Regulation

The clock has started ticking with the May 21 posting in the Federal Register to reclassify cannabis to Schedule III...

The potential rescheduling of cannabis may do little immediately to ease the path for cannabis companies to list on U.S. stock...

Approximately two weeks after the Department of Justice confirmed it was circulating a proposal to reschedule cannabis to Schedule III...

As state lawmakers across the country try to wrap their arms around the hemp-derived cannabinoid (HDC) conundrum, some do so...

New Mexico cannabis regulators are concerned about reports that licensed cannabis businesses have recently had their products seized by U.S....

It’s been 10 years since the U.S. Department of the Treasury’s Financial Crimes Enforcement Network, better known as FinCEN, has...

TerrAscend (TSNDF) and Ascend Wellness (AAWH) are following in the footsteps of Trulieve (TCNNF) in amending tax returns with the...

The difference between how the federal government views medical and adult-use cannabis could be at the center of Trulieve’s (TCNFF)...

As court cases challenging a state's authority to regulate or ban hemp-derived cannabinoids (HDCs) wend their way through courts, states...

As more politicians shine light on the potential for psychedelic medicine therapies, state bills and federal action have already begun...